Massachusetts General Hospital Cancer Center- Site Number : 1092 is a clinical research site located in Boston, Massachusetts, United States 02114-2603.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital Cancer Center- Site Number : 1092 has participated in 1 clinical trials.
Therapeutic areas: Immune Thrombocytopenia.
Sponsors: Principia Biopharma, a Sanofi Company.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital Cancer Center- Site Number : 1092 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital Cancer Center- Site Number : 1092 has 1 clinical trials on record. Their work covers Immune Thrombocytopenia.
Massachusetts General Hospital Cancer Center- Site Number : 1092 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.